Phase
Condition
N/ATreatment
Per-Operative Radiotherapy technique by Papillon +TM
Clinical Study ID
Ages > 65 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patient with invasive ductal adenocarcinoma <=2cm, evaluate on all radiologicalexams;
Women aged 65 years or older (patients 65 years of age in the year may be included);
Grade 1 or 2 unifocal adenocarcinoma, all index KI67, positive HR, negative HER2status;
T0 or T1, N0 radio-clinic;
Operable patient with breast volume compatible with conservative surgery;
Patient with prior malignancy or other concurrent malignancies are eligible,including bilateral breast cancer
Patients who have been made aware of the information sheet and have given theirwritten signed informed consent;
Patients benefitting from social health insurance coverage
Exclusion
Exclusion Criteria:
Age less than 65 years (except if 65 years obtained during the year)
Patient with an exclusive in situ carcinoma
Patient with lymphatic invasion / peri-nerve involvement / vascular emboli
Patient with a lobular adenocarcinoma
Patient with metastatic disease
Multifocal tumor
Patient with grade 3 or N+ disease
N1 proved by ultrasound guided
patient unable to express her consent
Patient deprived placed under the authority of a tutor
Female patients who are pregnant or breastfeeding
Vulnerable patient: as defined in article L1121-5 à -8
Study Design
Connect with a study center
Pôle Santé République
Clermont-Ferrand, 63000
FranceSite Not Available
Centre Antoine Lacassagne
Nice, 06189
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.